Local Drug Delivery

Otolaryngologic Clinics of North America

Volumn 42, Issue 5, 2009, Pages 829-845

  Harvey, Richard J ^a   Schlosser, Rodney J ^b  

^a Rhinology and Skull Base Surgery   (Australia)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Irrigation; Mucoadhesion; Sinus surgery; Spray; Steroid; Surfactant; Topical

Indexed keywords

ACETYLCYSTEINE; APOMORPHINE; BUDESONIDE; CARBOMER; CATIONIC SURFACTANT; CIPROFLOXACIN; CITRIC ACID ZWITTERIONIC SURFACTANT; CORTICOSTEROID; DORNASE ALFA; GENTAMICIN; HYDROXYPROPYLMETHYLCELLULOSE; IMMUNOGLOBULIN E; IONIC SURFACTANT; LUNG SURFACTANT; MACROGOL; MICROSPHERE; MUCIN; NANOPARTICLE; PSEUDOMONIC ACID; SODIUM CHLORIDE; STEROID; UNCLASSIFIED DRUG;

BIOFILM; CHRONIC DISEASE; CYSTIC FIBROSIS; DIFFUSION; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG RELEASE; DRUG SCREENING; ENDOSCOPIC SURGERY; GRAVITY; HEAD POSITION; HUMAN; LOCAL THERAPY; MEMBRANE PERMEABILITY; MICROENVIRONMENT; MUCOADHESION; MUCOCILIARY CLEARANCE; NEBULIZER; NONHUMAN; NOSE MUCOSA; NOSE SECRETION; NOSE SURGERY; PATHOPHYSIOLOGY; REVIEW; RHINITIS; RHINOSINUSITIS;

CHRONIC DISEASE; DRUG DELIVERY SYSTEMS; GLUCOCORTICOIDS; HUMANS; IRRIGATION; MUCOCILIARY CLEARANCE; NASAL MUCOSA; PARANASAL SINUS DISEASES; PARANASAL SINUSES; RHINITIS; SINUSITIS;

EID: 70350772366     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2009.07.005     Document Type: Review

References (95)

1. Fokkens W., Lund V., Mullol J., et al. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl (2007) 1-136
2. Kern R.C., Conley D.B., Walsh W., et al. Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. Am J Rhinol 22 (2008) 549-559
3. Lund V.J. Therapeutic targets in rhinosinusitis: infection or inflammation?. Medscape J Med 10 (2008) 105
4. Hatipoglu U., and Rubinstein I. Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm. Curr Allergy Asthma Rep 8 (2008) 154-161
5. Harvey R.J., Goddard J.C., Wise S.K., et al. Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation. Otolaryngol Head Neck Surg 139 (2008) 137-142
6. Snidvongs K., Chaowanapanja P., Aeumjaturapat S., et al. Does nasal irrigation enter paranasal sinuses in chronic rhinosinusitis?. Am J Rhinol 22 (2008) 483-486
7. Hyo N., Takano H., and Hyo Y. Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus. Rhinology 27 (1989) 17-26
8. Wormald P.-J., Cain T., Oates L., et al. A comparative study of three methods of nasal irrigation. Laryngoscope 114 (2004) 2224-2227
9. Olson D., Rasgon B., and Hilsinger R. Radiographic comparison of three methods for nasal saline irrigation. Laryngoscope 112 (2002) 1394-1398
10. Grobler A., Weitzel E.K., Buele A., et al. Pre- and postoperative sinus penetration of nasal irrigation. Laryngoscope 118 (2008) 2078-2081
11. Hwang P.H., Woo R.J., and Fong K.J. Intranasal deposition of nebulized saline: a radionuclide distribution study. Am J Rhinol 20 (2006) 255-261
12. DelGaudio J.M., and Wise S.K. Topical steroid drops for the treatment of sinus ostia stenosis in the postoperative period. Am J Rhinol 20 (2006) 563-567
13. Lavigne F., Cameron L., Renzi P.M., et al. Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope 112 (2002) 858-864
14. Mastalerz L., Milewski M., Duplaga M., et al. Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma. Allergy 52 (1997) 895-900
15. Qvarnberg Y., Kantola O., Salo J., et al. Influence of topical steroid treatment on maxillary sinusitis. Rhinology 30 (1992) 103-112
16. Parikh A., Scadding G.K., Darby Y., et al. Topical corticosteroids in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. Rhinology 39 (2001) 75-79
17. Dijkstra M.D., Ebbens F.A., Poublon R.M., et al. Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery. Clin Exp Allergy 34 (2004) 1395-1400
18. Chiu A.G., and Kennedy D.W. Disadvantages of minimal techniques for surgical management of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 12 (2004) 38-42
19. Valentine R., Athanasiadis T., Thwin M., et al. A prospective controlled trial of pulsed nasal nebulizer in maximally dissected cadavers. Am J Rhinol 22 (2008) 390-394
20. Miller T.R., Muntz H.R., Gilbert M.E., et al. Comparison of topical medication delivery systems after sinus surgery. Laryngoscope 114 2 (2004) 201-204
21. Merkus P., Ebbens F.A., Muller B., et al. The 'best method' of topical nasal drug delivery: comparison of seven techniques. Rhinology 44 (2006) 102-107
22. Karagama Y.G., Lancaster J.L., Karkanevatos A., et al. Delivery of nasal drops to the middle meatus: which is the best head position?. Rhinology 39 (2001) 226-229
23. Kayarkar R., Clifton N.J., and Woolford T.J. An evaluation of the best head position for instillation of steroid nose drops. Clin Otolaryngol Allied Sci 27 (2002) 18-21
24. Homer J.J., and Raine C.H. An endoscopic photographic comparison of nasal drug delivery by aqueous spray. Clin Otolaryngol Allied Sci 23 (1998) 560-563
25. Homer J.J., Maughan J., and Burniston M. A quantitative analysis of the intranasal delivery of topical nasal drugs to the middle meatus: spray versus drop administration. J Laryngol Otol 116 (2002) 10-13
26. Aggarwal R., Cardozo A., and Homer J.J. The assessment of topical nasal drug distribution. Clin Otolaryngol Allied Sci 29 (2004) 201-205
27. Tsikoudas A., and Homer J.J. The delivery of topical nasal sprays and drops to the middle meatus: a semiquantitative analysis. Clin Otolaryngol Allied Sci 26 (2001) 294-297
28. Cannady S.B., Batra P.S., Citardi M.J., et al. Comparison of delivery of topical medications to the paranasal sinuses via "vertex-to-floor" position and atomizer spray after FESS. Otolaryngol Head Neck Surg 133 (2005) 735-740
29. Benninger M.S., Hadley J.A., Osguthorpe J.D., et al. Techniques of intranasal steroid use. Otolaryngol Head Neck Surg 130 (2004) 5-24
30. Beule A., Athanasiadis T., Athanasiadis E., et al. Efficacy of different techniques of sinonasal irrigation after modified Lothrop procedure. Am J Rhinol Allergy 23 (2009) 85-90
31. Mestecky J. Mucosal immunology. 3rd edition, vol 2. In: Mestecky J. (Ed) (2005), Elsevier Academic Press, Amsterdam; London 1868-1918
32. Widdicombe J.G. Airway liquid: a barrier to drug diffusion?. Eur Respir J 10 (1997) 2194-2197
33. Lai S.K., Wang Y.Y., and Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 61 (2009) 158-171
34. Rogers D.F. Physiology of airway mucus secretion and pathophysiology of hypersecretion. Respir Care 52 (2007) 1134-1146 [discussion 1146-9]
35. Seaton A., MacNee W., Donaldson K., et al. Particulate air pollution and acute health effects. Lancet 345 (1995) 176-178
36. Rogers D.F., and Lethem M.I. Airway mucus: basic mechanisms and clinical perspectives (1997), Birkhauser Verlag, Basel
37. Aikawa T., Shimura S., Sasaki H., et al. Morphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary disease. Am Rev Respir Dis 140 (1989) 477-482
38. Openshaw P.J., and Turner-Warwick M. Observations on sputum production in patients with variable airflow obstruction; implications for the diagnosis of asthma and chronic bronchitis. Respir Med 83 (1989) 25-31
39. Rogers D.F. Airway mucus hypersecretion in asthma: an undervalued pathology?. Curr Opin Pharmacol 4 (2004) 241-250
40. Turner-Warwick M., and Openshaw P. Sputum in asthma. Postgrad Med J 63 Suppl 1 (1987) 79-82
41. Martinez-Anton A., Roca-Ferrer J., and Mullol J. Mucin gene expression in rhinitis syndromes. Curr Allergy Asthma Rep 6 (2006) 189-197
42. Kim D.H., Chu H.-S., Lee J.Y., et al. Up-regulation of MUC5AC and MUC5B mucin genes in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 130 (2004) 747-752
43. Agu R.U., Vu Dang H., Jorissen M., et al. Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium. Int J Pharm 237 (2002) 179-191
44. Hogman M., Mork A.C., and Roomans G.M. Hypertonic saline increases tight junction permeability in airway epithelium. Eur Respir J 20 (2002) 1444-1448
45. Slapak I., Skoupa J., Strnad P., et al. Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. Arch Otolaryngol Head Neck Surg 134 (2008) 67-74
46. Harvey R., Hannan S.A., Badia L., et al. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev 3 (2007) CD006394
47. Rogers D.F. Mucoactive agents for airway mucus hypersecretory diseases. Respir Care 52 (2007) 1176-1193 [discussion 1193-77]
48. Daviskas E., and Anderson S.D. Hyperosmolar agents and clearance of mucus in the diseased airway. J Aerosol Med 19 (2006) 100-109
49. Subiza J.L., Subiza J., Barjau M.C., et al. Inhibition of the seasonal IgE increase to Dactylis glomerata by daily sodium chloride nasal-sinus irrigation during the grass pollen season. J Allergy Clin Immunol 104 (1999) 711-712
50. Pynnonen M.A., Mukerji S.S., Kim H.M., et al. Nasal saline for chronic sinonasal symptons: a randomized controlled trail. Archi Otolaryngol-Head Neck Surg 133 (2007) 1115-1120
51. Gwaltney Jr. J.M., Hendley J.O., Phillips C.D., et al. Nose blowing propels nasal fluid into the paranasal sinuses. Clin Infect Dis 30 (2000) 387-391
52. Morgenroth K., and Bolz J. Morphological features of the interaction between mucus and surfactant on the bronchial mucosa. Respiration 47 (1985) 225-231
53. Sleigh M.A., Blake J.R., and Liron N. The propulsion of mucus by cilia. Am Rev Respir Dis 137 (1988) 726-741
54. Matsui H., Grubb B.R., Tarran R., et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95 (1998) 1005-1015
55. Tarran R., Grubb B.R., Gatzy J.T., et al. The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J Gen Physiol 118 (2001) 223-236
56. Widdicombe J. Airway and alveolar permeability and surface liquid thickness: theory. J Appl Physiol 82 (1997) 3-12
57. Thornton D.J., and Sheehan J.K. From mucins to mucus: toward a more coherent understanding of this essential barrier. Proc Am Thorac Soc 1 (2004) 54-61
58. Khanvilkar K., Donovan M.D., and Flanagan D.R. Drug transfer through mucus. Adv Drug Deliv Rev 48 (2001) 173-193
59. Larhed A.W., Artursson P., Grasjo J., et al. Diffusion of drugs in native and purified gastrointestinal mucus. J Pharm Sci 86 (1997) 660-665
60. Ugwoke M.I., Agu R.U., Verbeke N., et al. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev 57 (2005) 1640-1665
61. Rose M.C., and Voynow J.A. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86 (2006) 245-278
62. Rubin B.K. Physiology of airway mucus clearance. Respir Care 47 (2002) 761-768
63. Pena M.T., Aujla P.K., Patel K.M., et al. Immunohistochemical analyses of MUC5AC mucin expression in sinus mucosa of children with sinusitis and controls. Ann Otol Rhinol Laryngol 114 (2005) 958-965
64. Proctor D.F. The upper airways. I. Nasal physiology and defense of the lungs. Am Rev Respir Dis 115 (1977) 97-129
65. Illum L. Nasal drug delivery-possibilities, problems and solutions. J Control Release 87 (2003) 187-198
66. Saketkhoo K., Januszkiewicz A., and Sackner M.A. Effects of drinking hot water, cold water, and chicken soup on nasal mucus velocity and nasal airflow resistance. Chest 74 (1978) 408-410
67. Schuhl J.F. Nasal mucociliary clearance in perennial rhinitis. J Investig Allergol Clin Immunol 5 (1995) 333-336
68. Ali M.S., and Pearson J.P. Upper airway mucin gene expression: a review. Laryngoscope 117 (2007) 932-938
69. Bernkop-Schnurch A. Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliv Rev 57 (2005) 1569-1582
70. Prego C., Torres D., and Alonso M.J. The potential of chitosan for the oral administration of peptides. Expert Opin Drug Deliv 2 (2005) 843-854
71. Sam E., Jeanjean A.P., Maloteaux J.M., et al. Apomorphine pharmacokinetics in parkinsonism after intranasal and subcutaneous application. Eur J Drug Metab Pharmacokinet 20 (1995) 27-33
72. Petersen H., Kullberg A., Edsbacker S., et al. Nasal retention of budesonide and fluticasone in man: formation of airway mucosal budesonide-esters in vivo. Br J Clin Pharmacol 51 (2001) 159-163
73. Nakamura K., Maitani Y., Lowman A.M., et al. Uptake and release of budesonide from mucoadhesive, pH-sensitive copolymers and their application to nasal delivery. J Control Release 61 (1999) 329-335
74. Lim S.T., Martin G.P., Berry D.J., et al. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Control Release 66 (2000) 281-292
75. Lim S.T., Forbes B., Martin G.P., et al. In vivo and in vitro characterization of novel microparticulates based on hyaluronan and chitosan hydroglutamate. AAPS PharmSciTech 2 (2001) 20
76. Suzuki Y., and Makino Y. Mucosal drug delivery using cellulose derivatives as a functional polymer. J Control Release 62 (1999) 101-107
77. Sinswat P., and Tengamnuary P. Enhancing effect of chitosan on nasal absorption of salman calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins. Int J Phamaceutics 257 (2003) 15-22
78. Ozsoy Y., Tuncel T., Can A., et al. In vivo studies on nasal preparations of ciprofloxacin hydrochloride. Pharmazie 55 (2000) 607-609
79. Desrosiers M. Refractory chronic rhinosinusitis: pathophysiology and management of chronic rhinosinusitis persisting after endoscopic sinus surgery. Curr Allergy Asthma Rep 4 (2004) 200-207
80. Citardi M.J., and Kuhn F.A. Endoscopically guided frontal sinus beclomethasone instillation for refractory frontal sinus/recess mucosal edema and polyposis. Am J Rhinol 12 (1998) 179-182
81. Van Hamme J.D., Singh A., and Ward O.P. Physiological aspects. Part 1 in a series of papers devoted to surfactants in microbiology and biotechnology. Biotechnol Adv 24 (2006) 604-620
82. Chiu A.G., Palmer J.N., Woodworth B.A., et al. Baby shampoo nasal irrigations for the symptomatic postfunctional endoscopic sinus surgery patient. Am J Rhinol 22 (2008) 34-37
83. Desrosiers M., Myntti M., and James G. Methods for removing bacterial biofilms: in vitro study using clinical chronic rhinosinusitis specimens. Am J Rhinol 21 (2007) 527-532
84. Le T., Psaltis A., Tan L.W., et al. The efficacy of topical antibiofilm agents in a sheep model of rhinosinusitis. Am J Rhinol 22 (2008) 560-567
85. Lai S.K., Wang Y.Y., Wirtz D., et al. Micro- and macrorheology of mucus. Adv Drug Deliv Rev 61 (2009) 86-100
86. Shah P.L., Scott S.F., Knight R.A., et al. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis. Thorax 51 (1996) 119-125
87. Cimmino M., Nardone M., Cavaliere M., et al. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease. Arch Otolaryngol Head Neck Surg 131 (2005) 1097-1101
88. Dawson M., Wirtz D., and Hanes J. Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport. J Biol Chem 278 (2003) 50393-50401
89. Henke M.O., and Ratjen F. Mucolytics in cystic fibrosis. Paediatr Respir Rev 8 (2007) 24-29
90. Ferrari S., Kitson C., Farley R., et al. Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium. Gene Ther 8 (2001) 1380-1386
91. Hornof M.D., Kast C.E., and Bernkop-Schnurch A. In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates. Eur J Pharm Biopharm 55 (2003) 185-190
92. Bernkop-Schnurch A., Scholler S., and Biebel R.G. Development of controlled drug release systems based on thiolated polymers. J Control Release 66 (2000) 39-48
93. Park J.S., Oh Y.K., Yoon H., et al. In situ gelling and mucoadhesive polymer vehicles for controlled intranasal delivery of plasmid DNA. J Biomed Mater Res 59 (2002) 144-151
94. Lehr C.M. Lectin-mediated drug delivery: the second generation of bioadhesives. J Control Release 65 (2000) 19-29
95. Lai S.K., O'Hanlon D.E., Harrold S., et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A 104 (2007) 1482-1487